Literature DB >> 3384814

Electron microscopic examination of capsular material from various serotypes of Actinobacillus pleuropneumoniae.

M Jacques1, B Foiry, R Higgins, K R Mittal.   

Abstract

The capsular material on PPLO broth-grown cells of Actinobacillus pleuropneumoniae representing serotypes 1 to 10 was visualized by transmission electron microscopy after polycationic ferritin labeling and also after stabilization with specific antibodies. All the isolates examined were covered with a layer of capsular material whose thickness varied between 80 to 90 nm and 210 to 230 nm when examined by immunostabilization. We were also able to visualize A. pleuropneumoniae in lungs of infected pigs and to estimate the amount of capsular material covering the cells. Our results indicate that differences in capsular structure exist among the different A. pleuropneumoniae serotypes, and this result may explain in part why the serotypes are not equally virulent.

Entities:  

Mesh:

Year:  1988        PMID: 3384814      PMCID: PMC211291          DOI: 10.1128/jb.170.7.3314-3318.1988

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  29 in total

1.  Production of RNA-dependent haemolysin by Haemophilus pleuropneumoniae.

Authors:  P G Martin; P Lachance; D F Niven
Journal:  Can J Microbiol       Date:  1985-05       Impact factor: 2.419

2.  Identification and serotyping of Haemophilus pleuropneumoniae by coagglutination test.

Authors:  K R Mittal; R Higgins; S Larivière
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

3.  Organization of teichoic acid in the cell wall of Bacillus subtilis.

Authors:  D C Birdsell; R J Doyle; M Morgenstern
Journal:  J Bacteriol       Date:  1975-02       Impact factor: 3.490

4.  Morphological stabilization of the glycocalyces of 23 strains of five Bacteroides species using specific antisera.

Authors:  D W Lambe; K J Mayberry-Carson; K P Ferguson
Journal:  Can J Microbiol       Date:  1984-06       Impact factor: 2.419

Review 5.  Haemophilus pleuropneumoniae infection in swine: a review.

Authors:  T N Sebunya; J R Saunders
Journal:  J Am Vet Med Assoc       Date:  1983-06-15       Impact factor: 1.936

6.  Serological characterization of 8 Haemophilus pleuropneumoniae strains and proposal of a new serotype: serotype 8.

Authors:  R Nielsen; P J O'Connor
Journal:  Acta Vet Scand       Date:  1984       Impact factor: 1.695

7.  Toxicity of Haemophilus pleuropneumoniae for porcine lung macrophages, peripheral blood monocytes, and testicular cells.

Authors:  P H Bendixen; P E Shewen; S Rosendal; B N Wilkie
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

8.  Comparative virulence of porcine Haemophilus bacteria.

Authors:  S Rosendal; D A Boyd; K A Gilbride
Journal:  Can J Comp Med       Date:  1985-01

9.  Characterization of the hemolysin produced by haemophilus pleuropneumoniae.

Authors:  T Nakai; A Sawata; K Kume
Journal:  Am J Vet Res       Date:  1983-02       Impact factor: 1.156

10.  PORCINE CONTAGIOUS PLEUROPNEUMONIA. 3. INTERRELATIONSHIP OF HEMOPHILUS PLEUROPNEUMONIAE TO OTHER SPECIES OF HEMOPHILUS: NUTRITIONAL, METABOLIC, TRANSFORMATION, AND ELECTRON MICROSCOPY STUDIES.

Authors:  D C WHITE; G LEIDY; J D JAMIESON; R E SHOPE
Journal:  J Exp Med       Date:  1964-07-01       Impact factor: 14.307

View more
  14 in total

1.  Inhibition of bactericidal activity of anticapsular antibody by nonspecific antibodies reactive with surface-exposed antigenic determinants on Actinobacillus pleuropneumoniae.

Authors:  F A Udeze; S Kadis
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  Cross-reactions between Actinobacillus (Haemophilus) pleuropneumoniae strains of serotypes 1 and 9.

Authors:  K R Mittal
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Increase of glycocalyx and altered lectin agglutination profiles of Pasteurella haemolytica A1 after incubation in bovine subcutaneous tissue chambers in vivo or in ruminant serum in vitro.

Authors:  K Brogden; C Clarke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Role of lipopolysaccharides in adherence of Actinobacillus pleuropneumoniae to porcine tracheal rings.

Authors:  M Bélanger; D Dubreuil; J Harel; C Girard; M Jacques
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

5.  Eight Novel Capsular Polysaccharide Synthesis Gene Loci Identified in Nontypeable Streptococcus suis Isolates.

Authors:  Han Zheng; Shaobo Ji; Zhijie Liu; Ruiting Lan; Ying Huang; Xuemei Bai; Marcelo Gottschalk; Jianguo Xu
Journal:  Appl Environ Microbiol       Date:  2015-04-10       Impact factor: 4.792

6.  High-molecular-mass lipopolysaccharides are involved in Actinobacillus pleuropneumoniae adherence to porcine respiratory tract cells.

Authors:  S E Paradis; D Dubreuil; S Rioux; M Gottschalk; M Jacques
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

7.  Production of capsular material by Streptococcus suis serotype 2 under different growth conditions.

Authors:  M Gottschalk; R Higgins; M Jacques
Journal:  Can J Vet Res       Date:  1993-01       Impact factor: 1.310

8.  Further characterization of Vibrio vulnificus rugose variants and identification of a capsular and rugose exopolysaccharide gene cluster.

Authors:  Brenda L Grau; Margaret C Henk; Katherine L Garrison; Brett J Olivier; Randall M Schulz; Kathy L O'Reilly; Gregg S Pettis
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

9.  Association of Actinobacillus pleuropneumoniae capsular polysaccharide with virulence in pigs.

Authors:  Aloka B Bandara; Mark L Lawrence; Hugo P Veit; Thomas J Inzana
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Microarray-based comparative genomic profiling of reference strains and selected Canadian field isolates of Actinobacillus pleuropneumoniae.

Authors:  Julien Gouré; Wendy A Findlay; Vincent Deslandes; Anne Bouevitch; Simon J Foote; Janet I MacInnes; James W Coulton; John H E Nash; Mario Jacques
Journal:  BMC Genomics       Date:  2009-02-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.